Clin2
NCT07371728Likely a fitNot yet recruiting

Aprepitant for nausea after middle ear surgery

Otologic Disease

Treatments studied

Part of Ear, nose & throat clinical trials.

This study tests whether aprepitant helps prevent nausea and vomiting after middle ear surgery. If you are having this type of surgery, you may be able to join to help see if this medication improves recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are scheduled for middle ear surgery such as tympanoplasty, tympanomastoidectomy, or stapedectomy.
  • You must be able to fill out a short questionnaire after surgery.
  • You are not taking certain medications that could interact with the study drug (your doctor will check).
  • You are not pregnant or breastfeeding.
  • You are willing to use a backup birth control method for one month after surgery if you are on hormonal contraceptives.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06357234Recruiting· Phase 2
Aprepitant to prevent nausea after child scoliosis surgery

This trial tests if a drug called Aprepitant, given before surgery, can better prevent nausea and vomiting after scoliosis repair in children. It is for children aged 8 to 18 who are having spinal fusion surgery for a certain type of scoliosis.

Halifax, Nova Scotia
NCT07639723Not yet recruiting· Phase 4
Aprepitant for same-day discharge after knee replacement

This study tests if aprepitant, a medicine to prevent nausea, helps people leave the hospital sooner after knee replacement surgery. The goal is to see if it makes same-day discharge easier and more comfortable.

Skokie, Illinois
NCT05841849Not yet recruiting· Phase 4
Comparing IV versus oral anti-nausea drugs for breast cancer chemotherapy

This study compares two ways of giving anti-nausea medication: one through an IV (drip) and one as a pill. Both are paired with a newer drug to prevent nausea and vomiting caused by chemotherapy in breast cancer patients.

Hanzhou, Zhejiang
NCT05773950Enrolling by invitation
Triple medicine to prevent nausea after laparoscopic gynecologic surgery

This trial tests a combination of three medicines given during surgery to reduce nausea and vomiting after anesthesia. You might be eligible if you’re having laparoscopic gynecologic surgery and meet the age and health requirements.

Seoul, Seoul
NCT06417567Recruiting
Preventing nausea and vomiting after GI cancer surgery

This study tests whether the medication NEPA (Netupitant and Palonosetron) can prevent nausea and vomiting in people who have had surgery for liver, gallbladder, or pancreatic cancer. It may help those who want to avoid post-surgery sickness.

Tianjin, Tianjin Municipality
NCT07786155Not yet recruiting
Preventing nausea after head and neck flap surgery

This trial tests a combination of anti-nausea medicines given before, during, and after surgery to reduce nausea and vomiting. It is for people having flap surgery to treat head and neck cancer.

Hear when a new Otologic Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.